Sarana Meditama Valuation
| SAME Stock | IDR 250.00 8.00 3.10% |
At this time, the company appears to be overvalued. Sarana Meditama Metr has a current Real Value of 221.76 per share. The regular price of the company is 250.0. Our model measures the value of Sarana Meditama Metr from inspecting the company fundamentals such as Operating Margin of 0.01 %, return on equity of -0.0035, and Shares Outstanding of 17.13 B as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sarana Meditama's price fluctuation is very steady at this time. Calculation of the real value of Sarana Meditama Metr is based on 3 months time horizon. Increasing Sarana Meditama's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Sarana Meditama's intrinsic value may or may not be the same as its current market price of 250.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 250.0 | Real 221.76 | Hype 250.0 |
The intrinsic value of Sarana Meditama's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Sarana Meditama's stock price.
Estimating the potential upside or downside of Sarana Meditama Metropolitan helps investors to forecast how Sarana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sarana Meditama more accurately as focusing exclusively on Sarana Meditama's fundamentals will not take into account other important factors: Sarana Meditama Total Value Analysis
Sarana Meditama Metropolitan is at this time forecasted to have takeover price of 5.14 T with market capitalization of 5.31 T, debt of 20.94 B, and cash on hands of 470 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sarana Meditama fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.14 T | 5.31 T | 20.94 B | 470 B |
Sarana Meditama Investor Information
About 76.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.32. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sarana Meditama Metr has Price/Earnings (P/E) ratio of 177.12. The entity last dividend was issued on the 18th of May 2018. The firm had 5:1 split on the 2nd of June 2017. Based on the key measurements obtained from Sarana Meditama's financial statements, Sarana Meditama Metropolitan is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Sarana Meditama Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Sarana suggests not a very effective usage of assets in November.Sarana Meditama Ownership Allocation
Sarana Meditama Metr shows a total of 17.13 Billion outstanding shares. Sarana Meditama Metr has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.36 % of Sarana Meditama outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sarana Meditama Profitability Analysis
The company reported the revenue of 1.27 T. Net Income was 138.55 B with profit before overhead, payroll, taxes, and interest of 518.68 B.About Sarana Meditama Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Sarana Meditama Metropolitan. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Sarana Meditama Metr based exclusively on its fundamental and basic technical indicators. By analyzing Sarana Meditama's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Sarana Meditama's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sarana Meditama. We calculate exposure to Sarana Meditama's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sarana Meditama's related companies.PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia.
8 Steps to conduct Sarana Meditama's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sarana Meditama's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sarana Meditama's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sarana Meditama's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sarana Meditama's revenue streams: Identify Sarana Meditama's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sarana Meditama's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sarana Meditama's growth potential: Evaluate Sarana Meditama's management, business model, and growth potential.
- Determine Sarana Meditama's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sarana Meditama's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Sarana Stock
Sarana Meditama financial ratios help investors to determine whether Sarana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarana with respect to the benefits of owning Sarana Meditama security.